COX-3: just another COX or the solitary elusive target of paracetamol?
- 1 March 2003
- journal article
- Published by Elsevier in The Lancet
- Vol. 361 (9362) , 981-982
- https://doi.org/10.1016/s0140-6736(03)12841-3
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Cyclooxygenase-3 (COX-3): Filling in the gaps toward a COX continuum?Proceedings of the National Academy of Sciences, 2002
- COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expressionProceedings of the National Academy of Sciences, 2002
- Both Constitutive and Inducible Prostaglandin H Synthase Affect Dermal Wound Healing in MiceLaboratory Investigation, 2002
- Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid ArthritisNew England Journal of Medicine, 2000
- Mechanism of Action of Acetaminophen: Is There a Cyclooxygenase 3?Clinical Infectious Diseases, 2000
- COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory diseaseThe Lancet, 2000
- Characterization of a novel transcript of prostaglandin endoperoxide H synthase 1 with a tissue-specific profile of expressionBiochemical Journal, 1999
- Molecular characterization of the 5.2 KB isoform of the human cyclooxygenase-1 transcriptProstaglandins, 1996
- Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulcerationCell, 1995
- Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like DrugsNature New Biology, 1971